Cargando…

Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease

BACKGROUND: Coffee intake can decrease the risk for Parkinson's disease (PD). Its beneficial effects are allegedly mediated by caffeine through adenosine A(2A) receptor (A(2A)R) antagonist action. OBJECTIVE: We aimed to calculate occupancy rates of striatal A(2A)Rs by caffeine after coffee inta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishibashi, Kenji, Miura, Yoshiharu, Wagatsuma, Kei, Toyohara, Jun, Ishiwata, Kiichi, Ishii, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306703/
https://www.ncbi.nlm.nih.gov/pubmed/35001424
http://dx.doi.org/10.1002/mds.28897
_version_ 1784752600060526592
author Ishibashi, Kenji
Miura, Yoshiharu
Wagatsuma, Kei
Toyohara, Jun
Ishiwata, Kiichi
Ishii, Kenji
author_facet Ishibashi, Kenji
Miura, Yoshiharu
Wagatsuma, Kei
Toyohara, Jun
Ishiwata, Kiichi
Ishii, Kenji
author_sort Ishibashi, Kenji
collection PubMed
description BACKGROUND: Coffee intake can decrease the risk for Parkinson's disease (PD). Its beneficial effects are allegedly mediated by caffeine through adenosine A(2A) receptor (A(2A)R) antagonist action. OBJECTIVE: We aimed to calculate occupancy rates of striatal A(2A)Rs by caffeine after coffee intake in PD. METHODS: Five patients with PD underwent (11)C‐preladenant positron emission tomography scanning at baseline and after intake of coffee containing 129.5 mg (n = 3) or 259 mg (n = 2) of caffeine. Concurrently, serum caffeine levels were measured. RESULTS: The mean serum caffeine level (μg/mL) was 0.374 at baseline and increased to 4.48 and 8.92 by 129.5 and 259 mg of caffeine, respectively. The mean occupancy rates of striatal A(2A)Rs by 129.5 and 259 mg of caffeine were 54.2% and 65.1%, respectively. CONCLUSIONS: A sufficient A(2A)R occupancy can be obtained by drinking a cup of coffee, which is equivalent to approximately 100 mg of caffeine. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
format Online
Article
Text
id pubmed-9306703
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-93067032022-07-28 Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease Ishibashi, Kenji Miura, Yoshiharu Wagatsuma, Kei Toyohara, Jun Ishiwata, Kiichi Ishii, Kenji Mov Disord Regular Issue Articles BACKGROUND: Coffee intake can decrease the risk for Parkinson's disease (PD). Its beneficial effects are allegedly mediated by caffeine through adenosine A(2A) receptor (A(2A)R) antagonist action. OBJECTIVE: We aimed to calculate occupancy rates of striatal A(2A)Rs by caffeine after coffee intake in PD. METHODS: Five patients with PD underwent (11)C‐preladenant positron emission tomography scanning at baseline and after intake of coffee containing 129.5 mg (n = 3) or 259 mg (n = 2) of caffeine. Concurrently, serum caffeine levels were measured. RESULTS: The mean serum caffeine level (μg/mL) was 0.374 at baseline and increased to 4.48 and 8.92 by 129.5 and 259 mg of caffeine, respectively. The mean occupancy rates of striatal A(2A)Rs by 129.5 and 259 mg of caffeine were 54.2% and 65.1%, respectively. CONCLUSIONS: A sufficient A(2A)R occupancy can be obtained by drinking a cup of coffee, which is equivalent to approximately 100 mg of caffeine. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. John Wiley & Sons, Inc. 2022-01-09 2022-04 /pmc/articles/PMC9306703/ /pubmed/35001424 http://dx.doi.org/10.1002/mds.28897 Text en © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Regular Issue Articles
Ishibashi, Kenji
Miura, Yoshiharu
Wagatsuma, Kei
Toyohara, Jun
Ishiwata, Kiichi
Ishii, Kenji
Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
title Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
title_full Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
title_fullStr Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
title_full_unstemmed Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
title_short Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
title_sort adenosine a(2a) receptor occupancy by caffeine after coffee intake in parkinson's disease
topic Regular Issue Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306703/
https://www.ncbi.nlm.nih.gov/pubmed/35001424
http://dx.doi.org/10.1002/mds.28897
work_keys_str_mv AT ishibashikenji adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease
AT miurayoshiharu adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease
AT wagatsumakei adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease
AT toyoharajun adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease
AT ishiwatakiichi adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease
AT ishiikenji adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease